FDA-cleared rapid antigen test for simultaneous detection of Influenza A and B. Designed for clinical and point-of-care settings, this test delivers fast, reliable results to support timely diagnosis and patient management. Suitable for respiratory screening in healthcare facilities and retail pharm...
Manufactured by
Boston Easy Biotech Inc.
Gaithersburg MD, United States
Boston Easy Biotech offers a range of user-friendly diagnostic tests that obtain FDA 510(k) Cleared for home and professional use, including pregnancy, drug abuse test, and respiratory testing. Our products are designed for accuracy, quick results, and affordability, meeting the diverse health testing needs of our customers. Famwell™️ is Boston Easy Biotech’s brand offering rapid diagnostic testing solutions.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Innovita (Tang Shan) Biological Technology Co.,Ltd.
China · 3 relevant products
GenSure Biotech Inc.
China · 2 relevant products
Famwell
United States · 3 relevant products
70 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →14 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 117 closest product alternatives
Innovita (Tang Shan) Biological Technology Co.,Ltd. · China
A rapid diagnostic test designed for the detection and differentiation of Influenza A and Influenza B antigens in clinical specimens. This test provides quick results to support timely clinical decision-making and patient management.
GenSure Biotech Inc. · China
Rapid antigen detection test kit for simultaneous identification of Influenza A and B viruses from respiratory specimens. Delivers results within minutes using immunochromatographic technology, enabling point-of-care diagnosis in clinical and home settings. NMPA-approved for accurate respiratory pathogen screening.
Famwell · United States
FDA 510(k) cleared and CLIA waived cassette-format test for rapid detection of influenza A and B antigens from nasopharyngeal swabs. Provides results within 10 minutes with 85.7% positive predictive accuracy and high negative predictive accuracy. Packaged in boxes of 25 tests with 18-month shelf life.
114 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products